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th chromosome. It creates a protein that is 1480 aminoacids long and serves as a chloride ion channel on the apical surface of the epithelial cells. The result of the genetic defect is the osmotic gradient resulting from the active transport of sodium and chloride, the passage of chloride and sodium in the cell membranes and the corresponding water in them. This causes loss of function in exocrine glands due to increased viscosity of secretions and blockage of these glands. 1 Cystic fibrosis is a life-threatening disease usually seen in the Caucasian population. 2 Due to the deterioration of the chloride channels in the cell membrane, thickening of the secretion is observed. Due to this thickening, the lungs, pancreas and sweat glands are affected. As a result, the lungs are damaged due to excessive mucus production, inflammation in the airways, endobronchial infection and airway obstruction in these patients. 3 The degree of exercise capacity of cystic fibrosis patients is related to the severity of the disease. The factors limiting exercise are malnutrition and respiratory system's status. 2 Exercise is important in order to maintain the physical fitness levels of patients because myopathy and osteopenia develop due to the steroids used in cystic fibrosis. Exercise is limited initially due to respiratory problems, but quality of life increases after regular exercise. 4 Exercise testing should be performed in order to create a safe exercise plan suitable for patients. In a UK survey of patients with cystic fibrosis, the number of patients undergoing exercise testing was found to be less than 40%. 5 The purpose of this review is to emphasize the importance of exercise tests in children with cystic fibrosis and to examine the various exercises used in previous studies. In this review, the studies with children aged 4-18 years were examined. The studies examined in the review were published between 1986 and 2018 (31 April) . The articles we included in our review are shown in Table 1 . In the studies used in the review, the most important criteria were the diagnosis of cystic fibrosis and the performing of any exercise tests to determine exercise tolerance. Azime 
EXERCISE
Exercises are divided into two groups by the source of energy used and whether oxygen is used or not during them. To summarize the energy systems briefly; 1-Phosphogen system: Stored ATP (adenosine triphosphate) and phosphocreatine is used for energy (sprint, barbell). This energy system is used while performing high intensity activities that last 15-30 seconds. 2-Glycolytic energy system: Phosphorylation of adenosine diphosphate (ADP) is done by anaerobic glycolysis, which causes glycogen in muscle tissue to subside from pyruvic acid to lactic acid. (100 mt fast swimming, 2.5-3 minutes fast-intensive exercises). 3-Aerobic energy system: Entering of pyruvic acid directly into the crebs cycle, β-oxidation of fats and production of ATP by the introduction of mitochondrial oxygen transfer systems. Provides ATP for exercises lasting longer than 3 minutes.
Especially VO 2max , VO 2peak , FEV 1 , physical work capacity and peak power output is measured with exercise testing. VO 2max is the value at the point where the oxygen consumption value is plateaued during exercise. VO 2peak is the VO 2 value at the time the athlete cannot stand the exercise. Less than 80% of the predicted VO 2peak value was interpreted as low exercise capacity. 6 Exercise is limited for many reasons. In cystic fibrosis disease, respiratory factors and cachexia are the most important causes of exercise limitation. Almajed et al. analyzed the factors that determine exercise capacity and limit exercise in their review. This review classified the factors that influence exercise performance as respiratory, cardiac, musculoskeletal and physical activity. The most important cardiac factors were right and left ventricule dysfunction, low stroke volume and pulmonary hypertension. Respiratory factors were expiratory problems, weakness of respiratory muscles, increased work of breathing and hypoxemia. Musculoskeletal factors were low muscle mass, neural conduction problems and andropause. Decrease of physical activity causes FEV1 (forced expired volume in one second) to decrease as well, affecting exercise capacity negatively. 7 
EXERCISE TESTING
Exercise testing is a necessary application for all individuals engaged in exercise. It is recommended to perform these tests annually. History related to health and exercise should be taken in the exercise testing. Patient history should especially include questions about past exercise tests and whether the patient had any adverse reactions with those tests. Anthropometric measurements should be taken. Anthropometric evaluation is an essential feature of children exercise evaluation for determining malnutrition, cachexy, muscular mass loss, fat mass gain and adipose tissue redistribution. Anthropometric indicators are used to evaluate the prognosis of chronic and acute diseases.
Exercise testing is performed to determine the prognosis of the disease, exercise tolerance, mortality, effectiveness of treatment and exercise prescription. 8, 9 Exercise tests are divided into seven main groups. These groups are anaerobic tests, aerobic tests, endurance tests, force tests, flexibility tests, neuromuscular tests, functional tests specific to daily living activities. 10 Commonly used exercise tests are incremental, submaximal, maximal exercise tests or ramp test protocols, submaximal steady state constant load tests and timed distance walk tests. 2 In order to detect the basic performance capacity, submaximal exercise tests are performed to determine the incremental exercise tests, anaerobic ventilator threshold or lactate threshold. When the disease is severe, a maximal exercise test is performed to determine the safe exercise interval. The maximal exercise test is done with the treadmill and the electronic mechanical bicycle ergometer. 2 Children have short explosive and high intensity activities in daily life. The exercise capacity of children should therefore be determined by anaerobic tests where the force is measured. Step test, Harward
Step test, YMCA 12 The exercise tests and the parameters measured in exercise tests are shown in Table 2 .
CONTRAINDICATIONS FOR THE EXERCISE TESTING
The contraindications for the tests are; history of unstable angina or myocardial infarction in the last month, persistant tachycardia despite 10 minutes of rest, hypertension (systolic BP over 200 mmHg, diastolic BP over 100 mmHg), desaturation (SaO 2 lower than %88) or physical disabilities preventing regular exercise. 15 The test must be terminated if any of the following are reported; angina pectoris, signs of poor perfusion (ataxia, central cyanosis, cold clammy skin, dizziness, pallor, confusion, sweating), loss of consciousness, leg cramps, dyspnea, fatigue, tachycardia (heart rate over 210/min), desaturation (SpO 2 below %85), lack of cardiac response to exercise.
In addition, if the child indicates that he / she cannot continue the test and the rate of fatigue decreases to a certain level (eg falls below 60 rpm), then the exercise test must be terminated.
LABORATORY TESTS

1-WINGATE TEST (WAnT)
With this test, anaerobic exercise capacity and explosive power are measured. This test was developed in 1970 at the Wingate Institute in Israel. It is stated that the test consists of 4 circuits in some sources, 5 in some sources and 3 in others. These circuits are composed of warm-up, recovery, acceleration, wingate test and cool down stages.
In this test, the number of pedal revolutions in 30 seconds and resistance is evaluated. The resistance of the ergometer is set in the 2 nd and 3 rd seconds of the test. For the legs, Fleisc ergometer is used at 45 gr/weight (kg) and Monark ergometer is used at 75 gr/weight (kg). 35 gr/weight (kg) is applied for children under 15 years old. For the arms, 30 gr/weight (kg) in Fleisc ergometer and 50 gr/ weight (kg) in Monark ergometer are used.
Selvadurai et al. published a study that examined the relationship between exercise capacity of 97 children with cystic fibrosis who were aged between 8-17 and genetics. In order to determine the anaerobic capacity in the study, they used the Wingate test and the Bruce protocol to determine peak aerobic capacity. 16 Klijn and colleagues used the Wingate test in their study with 39 children with cystic fibrosis with a mean age of 13 years. The correlation between FEV1 and Wingate test was examined. At the end of the study, pulmonary functions and lean body weight were found to be important determinants of anaerobic capacity. 17 
2-CPET-CARDIOPULMONARY EXERCISE TEST
Exercise intolerance cannot be determined with pulmonary function tests performed at rest. Therefore, the CPET test is very important to determine exercise intolerance. The purpose of this test is to put pressure on the organs involved in exercise. For this reason, lower extremities with large muscle groups are preferred.
There are two types of applications. In the first one, the increasing test protocol, a constant pedal speed of 60 rpm is used. The test is terminated when the pedal speed falls below 40 rpm. The initial load and increases are determined by the characteristics of the patient so that the exercise can be maintained for 10-12 minutes. The second type is the constant load protocol, in which a fixed load is applied, the patient is asked to exercise as much as he can and the time is recorded.
The difference between exercise times before and after treatment is taken into account. Protocol selection is based on the patient's functional capacity and the purpose of the test. A treadmill or bicycle ergometer can be used for this purpose. The advantage of the treadmill is that the walking / running model is well known and operates more muscle groups than the bicycle ergometer. The European Cystic Fibrosis Study Group routinely uses CPET exercise test in children aged ≥10 years The UK uses walking tests more frequently. 4, 18 Weir et al. performed the CPET exercise test using the modified Godfrey protocol on 38 children with cystic fibrosis aged between 7-14. The test was modified by minimizing the large changes in power output. Ramp range is determined as 6.5-25 W/ min. Ramp increase was made in 10 sec intervals. The optimal test time is 8-12 minutes. Rpm was kept above 60. The power output is determined by the height of the children. Estimated value is calculated by dividing the ramp increase by 10. The parameters were taken from the measurements in the last 30 seconds of the test. In this study, the correlation between VO 2max and FEV 1 with disease stage was investigated. 95% of children completed the test successfully. As a result of the study, no correlation between VO 2max , VO 2peak , FEV 1 , BMI (Body mass index) and disease severity was found. 19 
3-BICYCLE ERGOMETER
G Go od df fr re ey y p pr ro ot to oc co ol l: : This protocol is used with bicycle ergometry. The load is increased with 1 minute intervals until the patient is fatigued. The goal is to complete the test in 8-12 minutes. Heart rate measurements and gas analyses are performed in the last 15 seconds of each increment cycle. The test is terminated when the patient can not continue with the test (the pedal speed falls below 60 rpm) or when the oxygen saturation falls below 80%. Kent et al. used the bicycle ergometer for a study they performed with children diagnosed with cystic fibrosis. 20 Cerny et al. used the bicycle ergometer to evaluate exercise tolerance and the improvement of pulmonary function during hospitalization. 21 Klijn et al. investigated the relationship between aerobic performance, pulmonary function and body composition in their studies with children with cystic fibrosis. The study included 79 children aged 4-18 years. In this study, treadmil test was performed according to Bruce protocol in children under 12 years of age, and tests were performed with electronic mechanical bicycle ergometer in children aged 12 and over. The load was increased by 15 W per minute and the pedal speed was desired to be 60 rpm. Throughout the test, children have been encouraged by verbal stimulation to ensure the best performance. 22 Respiratory gas analyses were performed during the test and lung volumes were measured. The measurement was performed by applying a V valve mask with a breath by breath method. Oxygen uptake (VO 2 ), carbon dioxide production (VCO 2 ), minute ventilation (VE), respiratory exchange rate (RER), pulse rate (HR) and SaO 2 (oxygen saturation) were measured. The highest VO 2 VO 2peak in the last 30 seconds of the test was measured.
A 9% increase in lean body weight change can be explained by the change in VO 2peak . Nutritional status is an important parameter affecting aerobic performance. This study showed that longitudinal changes in lung function are related to aerobic capacity. VO 2peak decreased as the lean body weight increased.
Werkman et al. used the Godfrey exercise protocol to estimate the VO 2max values in their studies with 363 cystic fibrosis patients with an average age of 14 years and 60 healthy controls. The workload was determined according to the height of the children (10W for children less than 120 cm in heigth, 15W for 120-150 cm and 20W for those taller than 150 cm). The workload is increased according to the compliance of the children at 1 minute intervals. In the study, the measured values were taken 30 seconds before the test was completed. At the end of the study, it is concluded that if the VO 2peak can not be measured directly, the estimated value of VO 2peak can be obtained only by bicycle ergometer. 23 Saynor et al. measured aerobic fitness (VO 2max ) in 14 children with cystic fibrosis aged 7-18, using the ramp protocol in maximal CPET. In the study, 14 children completed the exhausting ramp test to determine VO 2max . After 15 minutes recovery time, supramaximal (S max ) (applied with 110% of peak power output measured in ramp test) test was performed. At the end of the study, they found that supramaximal testing following CPET was a suitable method for measuring the VO 2max values of children with cystic fibrosis. In the ramp test, VO 2max was (1.83±0.78 L min -1 ) while in the supramaximal test it was (1.82±0.67 L min -1 ), but the difference was not statistically significant (p=0.88). 24 Keochkerian et al. performed a study with 18 children aged 10-14, 9 of who had cystic fibrosis. The aim of the study was to determine the respiratory strategies during exercise and to look at the correlation between these strategies and pulmonary function. Progressive testing was performed with ergocycle (ER 900, Jaeger, Germany). In this test, symptom-limited maximum ramp protocol was used by using electronic mechanical brake bicycle ergometer. Increases in load was determined according to the clinical status of each individual. Exercise test completed within 8-10 minutes. After 2 minutes of warm-up exercise, the test was started while the children were breathing stable. In the test, the burden of children with cystic fibrosis was increased to 10-15 W in every 90 seconds, and the load of healthy children was increased to 15-20 W. The increase was continued until the burnout level. P(0.1) was measured in the last 45 sec after each loading. 25 S St te ee ep p r ra am mp p t te es st t: : Bongers et al. used the step ramp test in their study with 40 children with cystic fibrosis aged 11-18 years. Twenty-five minutes after using salbutamol (800 µg), children underwent respiratory function test followed by an electrostatic ergometer with CPET and SRT tests. Between the two tests, a 15 min recovery time was left. The CPET exercise test was performed according to the Godfrey protocol. The maximal level was determined as the heart rate above 180 or the RER value above 1.0 value. Burnout level was measured using "OMNI Scale of Perceived Exertion''. 26 This scale included 10 levels.
The SRT test was started with a 25W resistance for 3 minutes and SRT was started with an increase of 2, 3, 4 W with 2 second intervals. The total increase in 10 sec was determined as 10 W for children shorter than 120 cm, 15 W for children between 120-150 cm, and 20 W for children taller than 150 cm. The pedal speed was kept between 60-80 rpm. Despite the warning, the point where it fell below 60 rpm was determined as peak exercise.
4-TREADMILL TESTS
Starts after 5-10 minutes of warm-up. A monitor is needed to determine the patient's heart rate every The initial speed is set at 2.74 km / hr (1.7 mph) and the slope is set at 10%. In sedantary individuals, the initial speed is set at 1.7 mph but the slope is kept at 0%. The speed and slope are increased by 2% with 3 minute intervals. Oxygen consumption is calculated using a formula that comprises of testing time and gas analysis.
Edlund et al. used the Bruce protocol to investigate the effects of the swimming program on pediatric patients with cystic fibrosis. The study included 14 male and 9 female patients with cystic fibrosis aged 7-14 years. 12 participants were included in the study and 11 were included in the control group. All patients in the experimental and control groups participated in the treadmil test. 12-lead ECG measurements and maximum oxygen uptake (VO 2max ) were measured in the test. 27 
FIELD TESTS
1 1--6 6 m mi in nu ut te e ( (6 6M MU UT T) ) w wa al lk k t te es st t: : Modified from 12 minutes running test. It is one of the field tests which measures the aerobic endurance of the patients. According to the test results, the intensity of walking exercises of children with cystic fibrosis is determined. The 6MWT test should be applied 2 times and the best walking distance should be recorded. Tests should be performed for at least 30 minutes between the tests. Dyspnea is evaluated by BORG scale.
Lima et al. performed the 6 minute walking test on a treadmill, after applying non-invasive ventilation for 30 minutes using BILEVEL mode (EPAP: 6cm H 2 O, IPAP:12cm H 2 O) on 13 children with cystic fibrosis, who were aged 7-17. 28 Initially, the speed of treadmill was started at 2.5 km/h. According to the participant's capacity, the speed was increased in 30 sec intervals not to exceed the speed limit of 7 km /h. As a result of the study, the walking distance after the use of noninvasive ventilator was 415.38±77.2 m and the walking distance of the test without using noninvasive ventilator was 386.92±84.89 m. In this study, Borg scale was used to evaluate dyspnea (Table 3). 2 2--S Sh hu ut tt tl le e w wa al lk ki in ng g t te es st t ( (S SW WT T) ): : It is a test type used to measure aerobic capacity. It was first applied in 1982 at the University of Montreal in Canada. It is a corridor test in which progressive walking speed is increased and there are two types.
I I--Walking speed increasing incrementally: It is based on increasing the speed of walking at every minute with sound stimulus and is a test for determining the peak oxygen consumption. The test is made as a round trip between two points at a distance of 10 meters. In these shuttle tours, the results of the last round are as follows: meters or rounds. The walking speed starts with 0.5 m/s and the speed increases by 0.17 m per second. There are twelve levels. The test criterion is to monitor fatigue or symptoms. During the test, cardiac side effects cannot be monitored.
I II I-Endurance shuttle walking test where the speed is constant. After a two-minute warm-up period, patients are asked to walk a distance of 10 meters. The constant speed is adjusted according to Azime 85% of the VO 2max determined in the shuttle test where the walking speed is gradually increasing. Total walking time is recorded. It is a more useful test for evaluation after pulmonary rehabilitation programs.
Cox et al. used a modified shuttle test to determine exercise tolerance in a study of 28 children with cystic fibrosis who were hospitalized and treated with antibiotics. The ages of the children were 7.6-17.6 (mean 12.7 years). In the study, children used fatigue scale. 29 As a result of the study, it was seen that shuttle walking test was a good choice in determining the effect of hospitalization and antibiotic treatment. There was a significant increase in walking distance. In the protocol used by Bradley et al. 10 m distance was determined and markings were made. Beep sound started the test. It contains 15 stages and allowed to run if the child wants. Each level consists of 1 min. Speed increased by 0.61 km per minute. The test was terminated when the individual could not continue or when 15 sets were completed. HR and SPO 2 measurements were performed before and after the test. 3 3--2 2--m mi in nu ut te e w wa al lk k t te es st t ( (2 2M MW WT T) ): : Upton et al. used the 2-minute walk test to determine exercise tolerance of 155 patients, 89 of who were healthy, 66 had cystic fibrosis and of those, 16 who had pneumonia. They used this test because they thought the 12-minute walk test and 6-minute walk test were more tolerable for children with adult airway disease. 30 Butland et al. claimed that 2 minute and 6 minute walk tests were well correlated with the longer tests. As a result of the test, there was a positive correlation between walking distance and height of the children. The test was carried out in a 35 meter flat hospital corridor, each 5 meters marked in the closed area. Children were asked not to run and were encouraged verbally every 5 minutes. After resting for 5-10 minutes, the test was repeated and if the distance was over, the result of the test was accepted as valid. In the study, Narang et al. evaluated the exercise capacity of 19 children with cystic fibrosis between the ages of 10 and 18 in a 3-minute step test. Dyspnea was evaluated by visual analog scale. 32 In the study, children were divided into groups of 13 and 6. First 13 children applied the bicycle ergometer. 6 children performed a 3-minute step test. Afterwards, 6 children who applied bicycle ergometry and 13 children applied 3 min step test. Heart rate and VAS (Visual Analogue Scale) values were compared during the application of children's step test and bicycle ergometer. The average heart rate change was 78 in the children's bicycle ergometer and 46 in the 3-minute step test. The VAS value was 42 mm after 3 minutes of step test, and 51 mm after the bicycle ergometer. The change in SO 2 value during the step test and the bicycle ergometer was not statistically significant. Subjects stepped up and down a commercially available single-step test as in previous studies, 8 set at a height of 15 cm (6 inches). The stepping procedure was demonstrated to the subject prior to the onset of exercise. The stepping rate was 30 per minute for 3 min, and this was controlled by a metronome. Subjects could stop if they felt tired or if the SaO 2 fell below 75%, in which case the total number of steps taken was recorded. The subjects were shown how to change the leading leg to reduce localized muscle fatigue, and standardized encouragement was given.
Cunha et al. evaluated the exercise tolerance of 16 children with cystic fibrosis using the 6 minute walk test. 33 The test was carried out in a 28-meter straight corridor. At the end of the study, it was observed that the walking distance was not affected by age but was affected by height. However, studies with children with cystic fibrosis showed a significant correlation between age and walking distance. Table 4 .
Arikan and his colleagues used the Munich Fitness Test without modification. In the study conducted with 20 healthy participants with 19 cystic fibrosis aged between 7 and 25 years, they used the MFT test to evaluate the motor performance of the participants. 13 The original effort scale (normal heart rate 60-200), defined by the Borg, consisting of a 6-20 scale, is used to measure all effort during physical activity. It was modified in 10 points scale. 37 Urguhart et al. conducted a review of cardiopulmonary exercise in children with cystic fibrosis. 38 In the study, it was concluded that pulmonary functions are not the only factors effective in determining exercise capacity but cardiovascular and musculoskeletal systems also play an important role. In their study, Rogers et al. examined the exercise test in children with cystic fibrosis. 39 
CONCLUSIONS
In studies that we examined, exercise test was performed to evaluate the effect of exercise, prognosis of disease, effect of treatment and quality of life in children with CF. Field and laboratory tests were applied to measure aerobic and anaerobic capacity.
Preferred field tests were 6-MWT, 2MWT, mMFT, MST, 3 minute step tests. Laboratory tests were performed using treadmill and bicycle ergometer. Bruce, Godfrey and Wingate protocols were used in laboratory tests. These test types and the duration of the tests were selected according to the anthropometric characteristics of children and the prognosis of the disease. These studies used parameters that, directly or indirectly showed cardiorespiratory function, such as VE, VO 2max , VO 2 , heart rate and FEV 1 . In the last years, 1 min sit-to-stand test and mMFT test were applied. However the studies that focus on those are few in number. Our recommendation is to emphasize on studies that has tests which evaluate the peripheral muscle strength of children . As the adaptation to exercise will develop over time, children may benefit from exercise during the execarbation period of the disease. The studies we have examined stated that exercise testings are generally not performed regularly and they have recommended exercise testing at least once a year. Our recommendation is to perform these tests before winter since respiratory infections exacerbate CF and their exercise prescription should be prepared.
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